FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for pantoprazole sodium from Mylan Pharmaceuticals Inc. under ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)